$0.26
Insights on Ontrak Inc.
Revenue is down for the last 3 quarters, 3.71M → 3.53M (in $), with an average decrease of 2.4% per quarter
Netprofit is up for the last 9 quarters, -20.05M → -6.39M (in $), with an average increase of 16.1% per quarter
In the last 1 year, Healthequity Inc has given 38.0% return, outperforming this stock by 128.3%
In the last 3 years, Healthequity Inc has given 0.1% return, outperforming this stock by 100.0%
3.85%
Downside
Day's Volatility :7.41%
Upside
3.7%
48.08%
Downside
52 Weeks Volatility :96.69%
Upside
93.63%
Period | Ontrak Inc. | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 71.43% | -0.2% | 0.0% |
6 Months | -53.95% | 9.7% | 0.0% |
1 Year | -90.33% | 10.6% | 0.0% |
3 Years | -99.86% | 18.5% | -22.6% |
Market Capitalization | 12.0M |
Book Value | $0.48 |
Earnings Per Share (EPS) | -1.15 |
Wall Street Target Price | 4.0 |
Profit Margin | -186.35% |
Operating Margin TTM | -148.62% |
Return On Assets TTM | -43.36% |
Return On Equity TTM | -172.45% |
Revenue TTM | 12.9M |
Revenue Per Share TTM | 0.51 |
Quarterly Revenue Growth YOY | 6.0% |
Gross Profit TTM | 7.1M |
EBITDA | -14.1M |
Diluted Eps TTM | -1.15 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.4 |
EPS Estimate Next Year | -0.23 |
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Next Quarter | -0.14 |
What analysts predicted
Upside of 1438.46%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 15.2M | ↑ 96.67% |
Net Income | -14.2M | ↑ 4.46% |
Net Profit Margin | -93.64% | ↑ 82.66% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 35.1M | ↑ 131.24% |
Net Income | -26.2M | ↑ 84.13% |
Net Profit Margin | -74.56% | ↑ 19.08% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 82.8M | ↑ 136.04% |
Net Income | -22.7M | ↓ 13.21% |
Net Profit Margin | -27.42% | ↑ 47.14% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 84.1M | ↑ 1.56% |
Net Income | -37.1M | ↑ 63.56% |
Net Profit Margin | -44.15% | ↓ 16.73% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 14.5M | ↓ 82.75% |
Net Income | -51.6M | ↑ 38.85% |
Net Profit Margin | -355.33% | ↓ 311.18% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 12.7M | ↓ 12.2% |
Net Income | -27.9M | ↓ 45.86% |
Net Profit Margin | -219.1% | ↑ 136.23% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.5M | ↓ 11.71% |
Net Income | -11.3M | ↓ 11.13% |
Net Profit Margin | -451.95% | ↓ 2.99% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.5M | ↑ 0.0% |
Net Income | -9.1M | ↓ 19.73% |
Net Profit Margin | -362.79% | ↑ 89.16% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 3.0M | ↑ 17.93% |
Net Income | -6.8M | ↓ 25.81% |
Net Profit Margin | -228.24% | ↑ 134.55% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 3.7M | ↑ 25.51% |
Net Income | -6.4M | ↓ 5.0% |
Net Profit Margin | -172.76% | ↑ 55.48% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 3.5M | ↓ 4.74% |
Net Income | -6.4M | ↓ 0.34% |
Net Profit Margin | -180.73% | ↓ 7.97% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 3.5M | ↑ 0.0% |
Net Income | -6.4M | ↑ 0.0% |
Net Profit Margin | -180.73% | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.3M | ↓ 4.25% |
Total Liabilities | 15.3M | ↑ 167.93% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 23.9M | ↑ 277.27% |
Total Liabilities | 47.8M | ↑ 212.43% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 144.7M | ↑ 506.59% |
Total Liabilities | 84.0M | ↑ 75.76% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 93.7M | ↓ 35.26% |
Total Liabilities | 48.1M | ↓ 42.67% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 25.8M | ↓ 72.51% |
Total Liabilities | 20.1M | ↓ 58.28% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 19.8M | ↓ 22.95% |
Total Liabilities | 5.6M | ↓ 72.24% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 25.8M | ↓ 15.99% |
Total Liabilities | 20.1M | ↑ 15.05% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 25.8M | ↑ 0.0% |
Total Liabilities | 20.1M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 22.6M | ↓ 12.22% |
Total Liabilities | 21.9M | ↑ 8.83% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 20.8M | ↓ 8.15% |
Total Liabilities | 25.4M | ↑ 16.21% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 19.8M | ↓ 4.44% |
Total Liabilities | 5.6M | ↓ 78.05% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 19.8M | ↑ 0.0% |
Total Liabilities | 5.6M | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.6M | ↑ 16.37% |
Investing Cash Flow | 62.0K | ↓ 115.01% |
Financing Cash Flow | 7.3M | ↓ 37.63% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -16.9M | ↑ 97.12% |
Investing Cash Flow | -4.6M | ↓ 7580.65% |
Financing Cash Flow | 27.3M | ↑ 274.49% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -6.3M | ↓ 62.83% |
Investing Cash Flow | -4.6M | ↑ 0.0% |
Financing Cash Flow | 100.1M | ↑ 266.05% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -26.2M | ↑ 316.35% |
Investing Cash Flow | -4.5M | ↓ 3.41% |
Financing Cash Flow | -6.6M | ↓ 106.62% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -24.0M | ↓ 8.37% |
Investing Cash Flow | -1.2M | ↓ 74.2% |
Financing Cash Flow | -31.1M | ↑ 369.32% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.4M | ↓ 82.59% |
Investing Cash Flow | -152.0K | ↓ 39.2% |
Financing Cash Flow | -623.0K | ↓ 111.22% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.4M | ↑ 0.0% |
Investing Cash Flow | -98.0K | ↓ 35.53% |
Financing Cash Flow | -623.0K | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.1M | ↑ 253.73% |
Investing Cash Flow | -98.0K | ↑ 0.0% |
Financing Cash Flow | 3.2M | ↓ 618.94% |
Sell
Neutral
Buy
Ontrak Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ontrak Inc. | 5.6% | -53.95% | -90.33% | -99.86% | -98.51% |
Solventum Corp | -14.04% | -19.52% | -19.52% | -19.52% | -19.52% |
Veeva Systems Inc. | -15.62% | -3.68% | -11.39% | -41.19% | 8.43% |
Ge Healthcare Technologies Inc. | -3.32% | 11.22% | -4.15% | 27.54% | 27.54% |
Healthequity Inc | 2.46% | 17.68% | 38.04% | -1.32% | 26.95% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ontrak Inc. | NA | NA | NA | -0.4 | -1.72 | -0.43 | NA | 0.48 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Veeva Systems Inc. | 51.25 | 51.25 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 22.68 | 22.68 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
Healthequity Inc | 127.63 | 127.63 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ontrak Inc. | Buy | $12.0M | -98.51% | NA | -186.35% |
Solventum Corp | Hold | $10.8B | -19.52% | NA | 15.73% |
Veeva Systems Inc. | Buy | $28.2B | 8.43% | 51.25 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $35.6B | 27.54% | 22.68 | 8.05% |
Healthequity Inc | Buy | $7.1B | 26.95% | 127.63 | 5.57% |
BlackRock Inc
Hudson Bay Capital Management LP
HRT FINANCIAL LLC
Vanguard Group Inc
Geode Capital Management, LLC
UBS Group AG
ontrak, inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. its ontrak pre (predict-recommend-engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. the company's technology-enabled, ontrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, copd, and congestive heart failure. the ontrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. the company
Organization | Ontrak Inc. |
Employees | 102 |
CEO | Mr. Brandon H. LaVerne |
Industry | Health Services |
A Spac I Acquisition Corp
$0.26
-1.52%
Keyarch Acquisition Corp
$0.26
-1.52%
Connexa Sports Technologies Inc
$0.26
-1.52%
Us Value Etf
$0.26
-1.52%
First Wave Biopharma Inc
$0.26
-1.52%
Global X Msci Next Emerging
$0.26
-1.52%
Fat Projects Acquisition Corp
$0.26
-1.52%
Goal Acquisitions Corp
$0.26
-1.52%
Capital Link Global Fintech
$0.26
-1.52%